Richard A. Fair
2018
In 2018, Richard A. Fair earned a total compensation of $3.3M as President and Chief Executive Officer at BELLICUM PHARMACEUTICALS.
Compensation breakdown
| Non-Equity Incentive Plan | $280,347 |
|---|---|
| Option Awards | $2,429,201 |
| Salary | $551,050 |
| Other | $17,527 |
| Total | $3,278,125 |
Fair received $2.4M in option awards, accounting for 74% of the total pay in 2018.
Fair also received $280.3K in non-equity incentive plan, $551.1K in salary and $17.5K in other compensation.
Rankings
In 2018, Richard A. Fair's compensation ranked 3,509th out of 14,244 executives tracked by ExecPay. In other words, Fair earned more than 75.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,509 out of 14,244 | 75th |
Division Manufacturing | 1,295 out of 5,759 | 78th |
Major group Chemicals And Allied Products | 454 out of 2,122 | 79th |
Industry group Drugs | 374 out of 1,811 | 79th |
Industry Pharmaceutical Preparations | 287 out of 1,385 | 79th |
Source: SEC filing on April 27, 2020.
Fair's colleagues
We found two more compensation records of executives who worked with Richard A. Fair at BELLICUM PHARMACEUTICALS in 2018.